A family has accused a pharmaceutical company of profiting from cells taken from a patient without consent in 1951, during her battle with cervical cancer. The cells were collected while she was nearing death, and the family contends that the company benefited from them without providing appropriate authorization or compensation.
The case centers on the ethical and legal implications of using biological materials obtained without informed consent, raising questions about ownership, recognition, and potential financial compensation for the individual's estate or relatives.